We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hatch, Waxman Agree on Increased OGD Funding, Differ on Data Exclusivity
Hatch, Waxman Agree on Increased OGD Funding, Differ on Data Exclusivity
September 18, 2009
User fees and increased funding for the Office of Generic Drugs (OGD) are essential to facilitate access to affordable generic drugs, two leading congressional lawmakers say.